References
- Navarro M, Cisneros Fajardo EJ, Fernandez Mestre M, Arrieche D, Marchan E. Synthesis, characterization, DNA binding study and biological activity against Leishmania mexicana of [Cu(dppz)2]BF4. J Inorg Biochem 2003;97:364–369.
- Rocha LG, Almeida JRGS, Macêdo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine 2005;12:514–535.
- Kolodziej H, Kiderlen AF. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells. Phytochemistry 2005;66:2056–2071.
- WHO. http://www.who.int/leishmaniasis/burden/en.
- Croft SL. The current status of antiparasite chemotherapy. Parasitology 1997;114:S3–S15.
- Engers HD, Bergquist R, Moddaber F. Progress on vaccines against parasites. Dev Biol Stand 1996;87:73–84.
- Brenzan MA, Nakamura CV, Dias Filho BP, Ueda-Nakamura T, Young MCM, Côrrea AG, Júnior JA, dos Santos AO, Cortez DAG. Structure-activity relationship of (-) mammea A/BB derivatives against Leishmania amazonensis. Biomed Pharmacother 2008;62:651–658.
- Mishra Bhuwan B, Kale Raju R, Singh Rakesh K, Tiwari Vinod K. Alkaloids: Future prospective to combat leishmaniasis. Fitoterapia 2009;2:81–90.
- Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Diseases 2004;27:305–318.
- Poorrajab F, Kabudanian Ardestani S, Emami S, Behrouzi Fardmoghadam M, Shafiee A, Foroumadi A. Nitroimidazolyl-1,3,4- thiadiazole-based anti-leishmanial agents: Synthesis and in vitro biological evaluation. Eur J Med Chem 2009;44:1758–1762.
- Mayence A, Vanden Eynde JJ, LeCour Jr L, Walker LA, Tekwani BL, Huang TL. Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents. Eur J Med Chem 2004;39:547–553.
- Khan F, Choudhary M, Rasheed M, Zia Ullah S, Hayat S, Kaukab F, Choudhary MI. Attaur Rahman M, Perveen S. Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues. Bioorg Med Chem 2003;11:1381–1387.
- Khan KM, Mughal UR, Ambreen N, Samreen Perveen, S, Choudhary MI. Synthesis and leishmanicidal activity of 2,3,4-substituted-5-imidazolones. J Enzyme Inhib Med Chem 2010;25:29–37.
- Pires JR, Saito C, Gomes SL, Giesbrecht AM, Amaral A. Investigation of 5-nitrofuran derivatives: synthesis, antibacterial activity, and quantitative structure-activity relationships. J Med Chem 2001;22:3673–3681.
- Muelas-Serrano S, Pérez-Serrano J, Gómez-Barroi A, Arán VJ, Rodríguez-Caabeiro F. Ultrastructural alterations induced by nifurtimox and another nitro derivative on epimastigotes of Trypanosoma cruzi. Parasitol Res 2002;2:97–101.
- Rodrigues RF, da Silva EF, Echevarria A, Fajardo Bonin R, Amaral VF, Leon LL, Canto Cavalheiro MM. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation. Eur J Med Chem 2007;42:1039–1043.
- da Silva EF, Canto Cavalheiro MM, Braz VR, Cysne Finkelstein L, Leon LL, Echevarria A. Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes. Eur J Med Chem 2002;37:979–984.
- Foroumadi A, Mansouri S, Kiani Z, Rahmani A. Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones. Eur J Med Chem 2003;38:851–854.
- Behrouzi-Fardmoghadam M, Poorrajab F, Ardestani SK, Emami S, Shafiee A, Foroumadi A. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. Bioorg Med Chem 2008;16:4509–4515.
- Foroumadi A, Rineh A, Emami S, Siavoshi F, Massarrat S, Safari F, Rajabalian S, Falahati M, Lotfali E, Shafiee A. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain. Bioorg Med Chem Lett 2008;18:3315–3320.
- Poorrajab F, Ardestani SK, Foroumadi A, Emami S, Kariminia A, Behrouzi-Fardmoghadam M, Shafiee A. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. Exp Parasitol 2009;121:323–330.
- Foroumadi A, Mirzaei M, Shafiee A. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Il Farmaco 2001;56:621–623.
- Foroumadi A, Daneshtalab M, Shafiee A. Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazole derivatives. Arzneim-Forsch Drug Res 1999;49:1035–1038.